List view / Grid view

Drug Development

 

article

European Pharmaceutical Review Issue 3 2022

17 June 2022 | By

In this issue experts explore the development of targeted protein degradation drugs, how potential legislative changes may impact the EU and selecting the right downstream process for bi-specific antibodies. Also featured in this journal, how RMM can enable efficient shutdown recovery, five critical areas for data integrity in life sciences…